Roivant Staying ‘Patient’ On Deals, Leaving Investors Waiting

(Peter Hurley/Roivant)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Interviews

More from Business